0001650840-21-000002.txt : 20211104
0001650840-21-000002.hdr.sgml : 20211104
20211104151916
ACCESSION NUMBER: 0001650840-21-000002
CONFORMED SUBMISSION TYPE: D/A
PUBLIC DOCUMENT COUNT: 1
ITEM INFORMATION: 06b
FILED AS OF DATE: 20211104
DATE AS OF CHANGE: 20211104
EFFECTIVENESS DATE: 20211104
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: Aerami Therapeutics Holdings, Inc.
CENTRAL INDEX KEY: 0001650840
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: D/A
SEC ACT: 1933 Act
SEC FILE NUMBER: 021-414428
FILM NUMBER: 211379593
BUSINESS ADDRESS:
STREET 1: 2520 MERIDIAN PARKWAY
STREET 2: SUITE 400
CITY: DURHAM
STATE: NC
ZIP: 27713
BUSINESS PHONE: 9195897495
MAIL ADDRESS:
STREET 1: 2520 MERIDIAN PARKWAY
STREET 2: SUITE 400
CITY: DURHAM
STATE: NC
ZIP: 27713
FORMER COMPANY:
FORMER CONFORMED NAME: Dance Biopharm Holdings, Inc.
DATE OF NAME CHANGE: 20150819
FORMER COMPANY:
FORMER CONFORMED NAME: Dance BioPharm Holdings, Inc.
DATE OF NAME CHANGE: 20150812
D/A
1
primary_doc.xml
X0708
D/A
LIVE
0001650840
Aerami Therapeutics Holdings, Inc.
2520 MERIDIAN PARKWAY
SUITE 400
DURHAM
NC
NORTH CAROLINA
27713
9195897495
DELAWARE
Dance Biopharm Holdings, Inc.
Dance BioPharm Holdings, Inc.
Corporation
true
ANNE
C.
WHITAKER
2520 MERIDIAN PARKWAY
SUITE 400
DURHAM
NC
NORTH CAROLINA
27713
Director
JOHN
S.
PATTON
2520 MERIDIAN PARKWAY
SUITE 400
DURHAM
NC
NORTH CAROLINA
27713
Director
STEVE
THORNTON
2520 MERIDIAN PARKWAY
SUITE 400
DURHAM
NC
NORTH CAROLINA
27713
Executive Officer
Director
ADAM
STERN
2520 MERIDIAN PARKWAY
SUITE 400
DURHAM
NC
NORTH CAROLINA
27713
Director
BILL
WELCH
2520 MERIDIAN PARKWAY
SUITE 400
DURHAM
NC
NORTH CAROLINA
27713
Director
K
JEFFREY
BELL
2520 MERIDIAN PARKWAY
SUITE 400
DURHAM
NC
NORTH CAROLINA
27713
Executive Officer
TIMM
CROWDER
2520 MERIDIAN PARKWAY
SUITE 400
DURHAM
NC
NORTH CAROLINA
27713
Executive Officer
DARLENE
DEPTULA-HICKS
2520 MERIDIAN PARKWAY
SUITE 400
DURHAM
NC
NORTH CAROLINA
27713
Director
Other Health Care
Decline to Disclose
- 06b
true
0001650840-21-000001
2021-09-17
false
true
false
0
AEGIS CAPITAL CORP.
15007
None
None
810 7th AVENUE
22nd FLOOR
NEW YORK
NY
NEW YORK
10019
All States
false
22250560
22250560
0
false
238
2221056
0
Warrants to purchase up to 10% of the number of shares sold in the offering will be issued to Placement Agent for nominal consideration.
0
Proceeds to be used for working capital and genl corporate purposes, incl officer and employee salaries & director fees. A portion of proceeds to be used to compensate Placement Agent. Adam Stern, a director of issuer, is an affiliate of Placement Agent.
false
Aerami Therapeutics Holdings, Inc.
/s/ Steven Thornton
Steven Thornton
Chief Executive Officer
2021-11-04